Scholar Rock vs Tectonic Therapeutic
SRRK and TECX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SRRK and TECX compare
Scholar Rock is the larger company, worth 13 times as much as Tectonic Therapeutic ($5.3B against $413M).
Tectonic Therapeutic scores higher on the StockData Score (7 against 2 for Scholar Rock), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SRRK | TECX |
|---|---|---|
| Size and price | ||
| Market cap | $5.3B | $413M |
| Share price | $43.20 | $21.14 |
| Change, 1 year | 40.2% | 12.1% |
| Change, 5 years | 46.3% | −58.6% |
| Beta (5Y) | 1.50 | 1.54 |
| Employees | 289 | 60 |
| StockData Score | ||
| Total score | 2 | 7 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 9231× | – |
| P/B | 31.2× | 1.8× (better) |
| FCF yield | −5.9% (better) | −16.8% |
| Profitability | ||
| Operating margin | −71732% | – |
| Net margin | −72563% | – |
| FCF margin | −54371% | – |
| Return on equity | −200% | −35.5% (better) |
| Financial health | ||
| Debt / equity | 1.16 (better) | 0.00 |
| Interest coverage | −29.2× (better) | −3216.4× |
| Current ratio | 5.41 | 19.71 (better) |
| Altman Z-score | 4.22 | 15.19 (better) |
| Piotroski F-score | 1 | 4 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Buyback yield | −3.1% | – |
| Shareholder yield | −3.1% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 114% | 71.4% |
| Held by insiders | 28.9% | 42.8% |
| Insider net buying, 12 months | −$7.4M | −$416K (better) |
| Short interest, % of float | 27.1% | 21.2% |
Go deeper
- SRRK stock overview
- SRRK income statement
- SRRK valuation and score
- TECX stock overview
- TECX income statement
- TECX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.